Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial–Mesenchymal Transition

Kentaro Tokumo(Hiroshima University), Noboru Hattori(Hiroshima University)
Cancers
February 8, 2023
Cited by 9


Related Papers